CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

All Therapeutic Areas
🧠

Neurology & CNS

70 drugs in pipeline from 10 companies

70

Drugs in Pipeline

10

Companies

6

Upcoming Catalysts

70

Phase 3 Trials

Upcoming Catalysts
2w
DNLIPhase 2

BIIB122 225 mg Phase 2 Results Expected

BIIB122 225 mg50
Apr 30
CT.gov
00%
2w
TLSAPhase 2

Foralumab TZLS-401 100 µg Phase 2 Results Expected

Foralumab TZLS-401 100 µg55
Apr 30
CT.gov
00%
2w
NVSPhase 3

Remibrutinib Phase 3 Results Expected

Remibrutinib1,011
Apr 30
CT.gov
00%
4w
BIIBPhase 2

BIIB080 Phase 2 Results Expected

BIIB080416
BTDFTOrphan
May 14
CT.gov
00%
4w
LLYPhase 2

Mevidalen Phase 2 Results Expected

Mevidalen300
May 15
CT.gov
00%
4w
BHVNPhase 3

BHV-7000 Phase 3 Results Expected

BHV-7000390
May 15
CT.gov
00%
Pipeline by Phase
Phase 3
70
Related Conditions
alzheimerparkinsonmultiple sclerosisepilepsystrokeneuropathydementiamigrainealshuntingtonseizurecnsneurologicalneurodegenerativebrainspinalnerveschizophreniadepressionanxietybipolaradhdautismpsychosisptsdocd